Identification of Early Interstitial Lung Disease in Smokers from the COPDGene Study

Academic Radiology

Volumn 17, Issue 1, 2010, Pages 48-53

  Washko, George R ^a   Lynch, David A ^b   Matsuoka, Shin ^a   Ross, James C ^a   Umeoka, Shigeaki ^a   Diaz, Alejandro ^a   Sciurba, Frank C ^c   Hunninghake, Gary M ^a   San José Estépar, Raúl ^b   Silverman, Edwin K ^a   Rosas, Ivan O ^a   Hatabu, Hiroto ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

CT scan; Early interstitial lung disease; smoker

Indexed keywords

TOBACCO SMOKE;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HUMAN; INTERSTITIAL LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCORING SYSTEM; SMOKING;

COMORBIDITY; FEMALE; HUMANS; INCIDENCE; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; RADIOGRAPHY, THORACIC; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SMOKING; TOMOGRAPHY, X-RAY COMPUTED; UNITED STATES;

EID: 71049138601     PISSN: 10766332     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acra.2009.07.016     Document Type: Article

References (25)

1. King T.E.J., Tooze J.A., Schwarz M.I., et al. Predicting survival in idiopathic pulmonary fibrosis. scoring system and survival model. Am J Respir Crit Care Med 164 (2001) 1171-1181
2. Raghu G., Weycker D., Edelsberg J., et al. Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 174 (2006) 810-816
3. Gross T.J., and Hunninghake G.W. Idiopathic pulmonary fibrosis. N Engl J Med 345 (2001) 517-525
4. Demedts M., Behr J., Buhl R., et al. High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med 353 (2005) 2229-2242
5. King Jr. T.E., Behr J., Brown K.K., et al. BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 177 (2008) 75-81
6. Rosas I.O., Ren P., Avila N.A., et al. Early interstitial lung disease in familial pulmonary fibrosis. Am J Respir Crit Care Med 176 (2007) 698-705
7. Lynch D.A., Sahin H., and Garg K. Prevalence of infiltrative lung disease identified on ct in participants in the national lung screening trial. Abstract RSNA (2008) SSQ04-04:609
8. Fisher R.A. On the interpretation of X2 from contingency tables, and the calculation of P. J R Stat Soc 85 (1922) 87094
9. Wilcoxon F. Individual comparisons by ranking methods. Biometrics 1 (1945) 80-83
10. Rabe K.F., Hurd S., Anzueto A., et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176 (2007) 532-555
11. Hankinson J.L., Odencrantz J.R., and Fedan K.B. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 159 (1999) 179-187
12. Attili A.K., Kazerooni E.A., Gross B.H., et al. Smoking-related interstitial lung disease: radiologic-clinical-pathologic correlation. Radiographics 28 (2008) 1383-1396
13. Gochuico B.R., Avila N.A., Chow C.K., et al. Progressive preclinical interstitial lung disease in rheumatoid arthritis. Arch Intern Med 168 (2008) 159-166
14. Caminati A., and Harari S. Smoking-related interstitial pneumonias and pulmonary Langerhans cell histiocytosis. Proc Am Thorac Soc 3 (2006) 299-306
15. Baumgartner K.B., Samet J.M., Stidley C.A., et al. Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 155 (1997) 242-248
16. Flaherty K.R., and Hunninghake G.G. Smoking: an injury with many lung manifestations. Am J Respir Crit Care Med 172 (2005) 1070-1071
17. Selman M., King T.E., and Pardo A. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 134 (2001) 136-151
18. Baran C.P., Opalek J.M., McMaken S., et al. Important roles for macrophage colony-stimulating factor, CC chemokine ligand 2, and mononuclear phagocytes in the pathogenesis of pulmonary fibrosis. Am J Respir Crit Care Med 176 (2007) 78-89
19. Nogee L.M., Dunbar A.E., Wert S.E., et al. A mutation in the surfactant protein C gene associated with familial interstitial lung disease. N Engl J Med 344 (2001) 573-579
20. Hodgson U., Laitinen T., and Tukiainen P. Nationwide prevalence of sporadic and familial idiopathic pulmonary fibrosis: evidence of founder effect among multiplex families in Finland. Thorax 57 (2002) 338-342
21. Steele M.P., Speer M.C., Loyd J.E., et al. Clinical and pathologic features of familial interstitial pneumonia. Am J Respir Crit Care Med 172 (2005) 1146-1152
22. Marshall R.P., Puddicombe A., Cookson W.O., et al. Adult familial cryptogenic fibrosing alveolitis in the United Kingdom. Thorax 55 (2000) 143-146
23. Bitterman P.B., Rennard S.I., Keogh B.A., et al. Familial idiopathic pulmonary fibrosis. Evidence of lung inflammation in unaffected family members. N Engl J Med 314 (1986) 1343-1347
24. Tsakiri K.D., Cronkhite J.T., Kuan P.J., et al. Adult-onset pulmonary fibrosis caused by mutations in telomerase. Proc Natl Acad Sci U S A 104 (2007) 7552-7557
25. Armanios M.Y., Chen J.J.L., Cogan J.D., et al. Telomerase mutations in families with idiopathic pulmonary fibrosis. N Engl J Med 356 (2007) 1317-1326